According to WIRED, Paterna claims it has worked out the molecular signals needed to turn spermatogonial stem cells into ...
Supports early-stage, high-growth North Dakota businesses by matching private angel investments with direct equity or ...
In the book, “Priority Technologies,” MIT faculty analyze how the U.S. can move ahead in multiple key industrial sectors — semiconductors, biotechnology, critical minerals, drones, quantum computing, ...
From fractional CFO to data consultant, these 10 roles pay $75+ an hour and let you set your own schedule. Here's what each ...
Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the best low priced biotech stocks to invest in. On April 13, H.C.
Egoz Hakfar CEO brings noodles, sauces and Asian ingredients for NIS 4.80–27. Also: ASICS 20g running shoes, Molecule 01 ...
This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for ...
The brokerage, in its recent note has sharply cut the target price to Rs 1,190 from the previous target price of Rs 1,680.
Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...
Nektar Therapeutics releases positive results from its trial for the treatment of alopecia areata.
Calling it a textbook classic move, he stated that we had a geopolitical shock and markets sold off hard before snapping ...
Many psychologists do not use lab notebooks, traditionally a key part of science. Here are ideas for returning to the lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results